-
-
-
-
-
-
-
SALP will acquire all issued and outstanding common shares of Liminal BioSciences (LMNL)
-
-
-
-
-
-
-
Liminal BioSciences Reports Second Quarter 2022 Financial Results and Business Highlights
-
-
-
-
-
-
-
Liminal BioSciences Announces Closing of Divestiture of Plasma Collection Centers and Enters into Option Agreement with Kedrion
-
-
-
-
-
-
-
Liminal BioSciences reports financial results for Q2-2020
-
1,154,926 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

